GluCARE develops the next generation Continuous Glucose Monitoring (CGM) device for minimally invasive, long-term, reliable and low cost continuous monitoring of glucose in the body. Within GluCARE we will validate in-vitro a continuous glucose monitoring (CGM) system and leverage its valorization.